Literature DB >> 14605708

[Intratympanic interval therapy of Menière disease with gentamicin with preserving cochlear function].

G Lange1, W Mann, J Maurer.   

Abstract

For the effective treatment of Menière's disease, gentamicin should be administered at most three times: on days 1, 8 and 15. More than 50% ( n=30) of 57 patients seen between 1997 and 2000 only needed a single dose of gentamicin to obtain a sufficient reaction (single shot-therapy). Vertigo attacks were controlled in 95% of our 57 patients and there were no substantial hearing losses. Four patients lost 15 dB. Tinnitus (46%) and ear pressure (69%) could be controlled or improved. The intratympanic injection-technique (single dose=0.3 ml=12 mg) performed under local anaesthesia is simple and superior to any other procedure. The peak concentration of gentamicin is reached after 2-6 days (average 4.6 days). As soon as signs of inner ear reaction are observed, treatment has been effective and must be stopped immediately to avoid over-intoxication and damage to the cochlea.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605708     DOI: 10.1007/s00106-003-0841-y

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  10 in total

Review 1.  Update on intratympanic gentamicin for Meniere's disease.

Authors:  B W Blakley
Journal:  Laryngoscope       Date:  2000-02       Impact factor: 3.325

2.  [Gentamicin injection technique. A simplification of transtympanic therapy of Menière disease].

Authors:  G Lange
Journal:  HNO       Date:  1998-12       Impact factor: 1.284

3.  Delayed onset of ototoxic effects of gentamicin in treatment of Menière's disease.

Authors:  M Magnusson; S Padoan; M Karlberg; R Johansson
Journal:  Acta Otolaryngol Suppl       Date:  1991

4.  Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

Review 5.  Clinical forum: a review of intratympanic therapy.

Authors:  B W Blakley
Journal:  Am J Otol       Date:  1997-07

6.  Intratympanic gentamicin titration therapy for intractable Meniere's disease.

Authors:  J T Atlas; L S Parnes
Journal:  Am J Otol       Date:  1999-05

7.  Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results.

Authors:  C L Driscoll; J L Kasperbauer; G W Facer; S G Harner; C W Beatty
Journal:  Laryngoscope       Date:  1997-01       Impact factor: 3.325

8.  Indications and results of gentamycin injection into the middle ear of patients with meniére's disease.

Authors:  S Watanabe; I Kato; K Takahashi; K Yoshino; I Takeyama
Journal:  Acta Otolaryngol Suppl       Date:  1995

9.  [Subablative gentamycin therapy in Menière's disease].

Authors:  F Hoffmann; C Beck; C Beck; S Stratulat
Journal:  HNO       Date:  1993-06       Impact factor: 1.284

10.  Pharmacokinetics of gentamicin in perilymph and endolymph of the rat as determined by radioimmunoassay.

Authors:  P Tran Ba Huy; C Manuel; A Meulemans; O Sterkers; C Amiel
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

  10 in total
  6 in total

1.  [Transtympanic administration of gentamicin in Menière diseases--less is more!?].

Authors:  A Koitschev
Journal:  HNO       Date:  2003-11       Impact factor: 1.284

Review 2.  [Endolymph homeostasis and Menière's disease: fundamentals, pathological changes, aminoglycosides].

Authors:  O Gleich; J Strutz; K Schmid
Journal:  HNO       Date:  2008-12       Impact factor: 1.284

Review 3.  [Surgical therapy in Menière's disease. Historical development and today's state of the art].

Authors:  G Baier; I Ott
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

4.  Localization of gentamicin uptake in the acutely isolated inner ear of the rat.

Authors:  Katharina Schmid; Jürgen Strutz; Otto Gleich; Pingling Kwok
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-03-28

Review 5.  [Management of the patient with Meniere's disease. Clear diagnosis but vertigo-provoking perspective].

Authors:  H Schaaf; H Holtmann
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

6.  Procedures for restoring vestibular disorders.

Authors:  Leif Erik Walther
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.